Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03196102 · ClinicalTrials.gov registry record · NA
Evaluation of a Brief Tobacco Intervention in the US Military
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 2,999
- Enrollment target
NCT03196102: Completed NA study, sponsored by University of Virginia.
NCT03196102 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 2,999 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (114% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03196102, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,999 participants
- Enrollment target
Study Summary
While the military has taken steps to reduce tobacco use over the past two decades, over a quarter of new military recruits report regular tobacco use prior to enlistment. This rate is higher than the national prevalence of 21.3% of US adults. Brief health prevention programs may be particularly effective for Airmen in Technical Training, given that all Airmen have been tobacco free for 11 ½ weeks and nearly 2/3rds are confident that they won't return to tobacco. We have developed and validated a Brief Tobacco Intervention (BTI) that is currently being implemented as part of Technical Training. We found that a motivational interviewing based, 40 minute BTI was efficacious in increasing perceived harm and decreasing intentions to use tobacco in a sample of 1055 Air Force trainees. Although we obtained significant positive changes in latent cognitive constructs for tobacco behavior that are highly predictive of future tobacco use in youth and young adults, the Little et al study did not obtain measures of actual tobacco resumption following the ban on tobacco in Air Force training. Given that 69.8% of all tobacco resumption/initiation occurs in Technical Training, a study that evaluates the short-term impact of our BTI on actual tobacco use is necessary prior to conducting the full scale R01 that would evaluate the long term efficacy of the BTI intervention. Thus, we propose the following Specific Aims: (1) To recruit approximately 2,000 Air Force trainees at the beginning of Technical Training at Joint Base San Antonio-Lackland Air Force in San Antonio, Texas during the 11 ½ week involuntary cessation ban; (2) To randomize participants to either (a) receive our cigarette smoking military tailored pamphlet (HL095758), The Airmen's Guide to Remaining Tobacco Free (Airmen's Guide; which has been disseminated and is now the standard of care in the Air Force) or (b) the Airmen's Guide + Brief Tobacco Intervention (BTI); (3) To determine the short-term (3 month, end of Tec
Primary Outcome
No tobacco use at 3 month follow-up since pre-assessment
Interventions
- BEHAVIORAL Standard smoking cessation intervention
- BEHAVIORAL BTI
- BEHAVIORAL Cigarette smoking military tailored pamphlet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,999 participants |
| Start Date | 2017-04-05 |
| Est. Completion | 2018-01-31 |
| Phase | NA |
What the finished NCT03196102 record still lists
NCT03196102 is an interventional study that assigns participants to a tested intervention. Its 2,999 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (114% higher).
The record links to 0 conditions, and to 3 interventions - of which Standard smoking cessation intervention is the first listed.
NCT03196102 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03196102 about?
NCT03196102 is a clinical study titled "Evaluation of a Brief Tobacco Intervention in the US Military". While the military has taken steps to reduce tobacco use over the past two decades, over a quarter of new military recruits report regular tobacco use prior to enlistment. This rate is higher than the national prevalence of 21.3% of US adults. Brief health prevention programs may be particularly eff...
What is the current status of trial NCT03196102?
This trial is currently completed. It is a NA study. The enrollment target is 2,999 participants. The study started on 2017-04-05. Estimated completion is 2018-01-31.
What interventions are being tested in trial NCT03196102?
The interventions under investigation include: Standard smoking cessation intervention (BEHAVIORAL), BTI (BEHAVIORAL), Cigarette smoking military tailored pamphlet (BEHAVIORAL).
Who is sponsoring clinical trial NCT03196102?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03196102's enrollment target sits among peer trials
2,999 42nd of 2000 higher than 1,959 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI